Xenon Corp (XENE) Bozor qiymatining balans qiymatiga nisbati
Xenon Pharmaceuticals (XENE) narxlar grafigi nevrologik patologiyalar uchun zamonaviy davolash usullarini ishlab chiqayotgan kompaniyaning dinamikasini aks ettiradi, bu sohada yangi terapiyalarga bo'lgan talab juda yuqori bo'lib qolmoqda. Faoliyat investitsiyalar va sherikliklar orqali moliyalashtirilmoqda, bunda joriy ko'rsatkich 2.81 ni tashkil etadi. O'sish istiqbollari XEN1101 ning 3-fazali sinovlari natijalari, tartibga soluvchi organlarning tasdig'i va ishlanmalarni moliyalashtirish hajmi bilan bog'liq.
Xenon Pharmaceuticals Inc. (XENE) - koʻrsatkichlar kesimi va moliyaviy hisobotlar
- aksiya kursi va ekspertlarning narx prognozi:
- bozor kapitallashuvi tafsilotlari:
- balans kapitallashuvi bo'yicha ma'lumotlar:
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Qarzning xususiy kapitalga nisbati Xenon Pharmaceuticals|XENE - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning o'z kapitaliga nisbati Xenon Pharmaceuticals Inc|XENE - Kompaniyaning umumiy yig'indi qarzi|Qarzning balans qiymatiga nisbati Xenon Pharmaceuticals Inc|XENE - Kompaniyaning uzoq muddatli qarzdorligi|Kompaniyaning qisqa muddatli qarzlari Xenon Pharmaceuticals
Kompaniyaning har tomonlama tahlili:Xenon Pharmaceuticals, XENE
Xenon Pharmaceuticals (XENE) uchun nisbiy kapitalizatsiya ko'rsatkichi, asosan tartibga soluvchi qarorlarga bog'liq bo'lgan no-tsiklik epilepsiya ishlanmalarining muvaffaqiyatiga bo'lgan bozor ishonchini aks ettiradi. Ushbu ko'rsatkich emitentning bozor qiymatining uning sof aktivlariga nisbati sifatida hisoblanadi, bu esa investorlarga biznesning haqiqiy to'lov qobiliyatini va bozor tebranishlari davrida kapitalning yo'qolish xavfini tezda baholash imkonini beradi.
Muhim raqobatchilar
BIIB: Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti neurocrine.com (NBIX)|Bozor qiymatining balans qiymatiga nisbati Regencell Bioscience Holdings Limited|Kapitallashuvning balans qiymatiga nisbati AXSM (Axsome)|Bozor kapitallashuvining balans qiymatiga nisbati ACAD|VKTX - Bozor qiymatining balans qiymatiga koeffitsiyenti|Supernus Pharmaceuticals - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati catalystpharma.com CPRX|DNLI - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati HRMY (Harmony Biosciences Inc)|Biohaven Pharmaceutical (BHVN) - Bozor qiymatining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Amylyx Corp (AMLX)|Kapitallashuvning sof aktivlarga nisbati TRVI|Kapitallashuvning balans qiymatiga nisbati PRAX (praxismedicines.com)|Bozor kapitallashuvining balans qiymatiga nisbati AVXL|CBLL - Bozor qiymatining balans qiymatiga koeffitsiyenti|Bozor qiymatining balans qiymatiga nisbati prothena.com PRTA|ALEC: Kapitallashuvning balans qiymatiga nisbati|ANNX - Bozor qiymatining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Omeros Corporation|Neurogene (NGNE) - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning balans qiymatiga nisbati ACIU|Kapitallashuvning sof aktivlarga nisbati VYGR|NMRA: Balans qiymatiga nisbatan bozor qiymati|Bozor qiymatining balans qiymatiga nisbati Scilex Holding Company (SCLX)|TVGN: Sof aktivlarga nisbatan bozor kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati ACOG (Alpha Cognition Inc.)|Balans qiymatiga nisbatan bozor qiymati CGTX|Inhibikase - Bozor kapitallashuvining balans qiymatiga nisbati|SAVA - Bozor kapitallashuvining balans qiymatiga nisbati|assertiotx.com (ASRT) - Bozor qiymatining balans qiymatiga nisbati|Coya Therapeutics - Balans qiymatiga nisbatan bozor qiymati|Bozor qiymatining balans qiymatiga nisbati VistaGen Therapeutics, Inc.|Kapitallashuvning sof aktivlarga nisbati Ovid Rx (OVID)|Bozor kapitallashuvining balans qiymatiga nisbati ABOS|Bozor kapitallashuvining balans qiymatiga nisbati CervoMed Corporation (CRVO)|Bozor kapitallashuvining balans qiymatiga nisbati ATHE (Alterity Therapeutics Limited)|CLNN - Kapitallashuvning sof aktivlarga nisbati|PepGen Corp - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti jupiterneurosciences.com|RLMD (Relmada) - Kapitallashuvning sof aktivlarga nisbati|Annovis Bio Corporation (ANVS) - Bozor kapitallashuvining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati GRCE|AIFF (fireflyneuro.com) - Bozor kapitallashuvining balans qiymatiga multiplikatori|Bozor kapitallashuvining balans qiymatiga nisbati KLTO|Balans qiymatiga nisbatan bozor kapitallashuvi neurosense-tx.com|Bozor kapitallashuvining balans qiymatiga nisbati RVPH (Reviva Pharmaceuticals Holdings)|MTVA - Kapitallashuvning sof aktivlarga nisbati|NeurAxis, Inc. - Bozor kapitallashuvining balans qiymatiga nisbati|HSDT - Bozor kapitallashuvining balans qiymatiga nisbati|passagebio.com (PASG) - Bozor qiymatining balans qiymatiga nisbati|NEUP (Neuphoria Therapeutics) - Bozor qiymatining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Minerva Neurosciences Corp|Athira Pharma Corp (ATHA) - Balans qiymatiga nisbatan bozor kapitallashuvi|Kapitallashuvning sof aktivlarga nisbati ADXN (Addex Therapeutics)|alzamend.com - Kapitallashuvning balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati CYCN (Cyclerion Therapeutics, Inc.)|Protagenic Therapeutics Inc. (PTIX) - Bozor qiymatining balans qiymatiga koeffitsiyenti|KTTA - Bozor qiymatining balans qiymatiga nisbati|CRGT (Cortigent, Inc.) - Kapitallashuvning balans qiymatiga nisbati|ATXI: Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti brainstorm-cell.com (BCLI)|Bozor qiymatining balans qiymatiga nisbati Cara Therapeutics|Kapitallashuvning balans qiymatiga nisbati CHRO (Chromocell Therapeutics Corp)|Bozor kapitallashuvining balans qiymatiga nisbati ELYM|ITCI - Bozor qiymatining balans qiymatiga koeffitsiyenti|Longboard Pharmaceuticals - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati marinuspharma.com MRNS|NKGN - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati NRBO (NeuroBo Pharmaceuticals Inc)|Sage Therapeutics, Inc (SAGE) - Bozor qiymatining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Synaptogenix, Inc (SNPX)|Kapitallashuvning sof aktivlarga nisbati TRVN|Kapitallashuvning balans qiymatiga nisbati VIGL (Vigil Neuro)|Bozor kapitallashuvining balans qiymatiga nisbati WENA|CERE - Bozor qiymatining balans qiymatiga koeffitsiyenti